SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-016062
Filing Date
2024-02-16
Accepted
2024-02-15 18:13:08
Documents
5
Effectiveness Date
2024-02-16

Document Format Files

Seq Description Document Type Size
1 S-8 2024_s8.htm S-8 114312
2 EX-5.1 prld-ex5_1.htm EX-5.1 17320
3 EX-23.2 prld-ex23_2.htm EX-23.2 3347
4 EX-FILING FEES prld-exfiling_fees.htm EX-FILING FEES 24719
5 GRAPHIC img162401780_0.jpg GRAPHIC 44263
  Complete submission text file 0000950170-24-016062.txt   221875
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277122 | Film No.: 24645210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)